title: Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
abstract: The invasive phenotype of glioblastoma multiforme (GBM) is a hallmark of malignant process, yet molecular mechanisms that dictate this locally invasive behavior remain poorly understood. Gene expression profiles of human glioma cells were assessed from laser capture-microdissected GBM cells collected from paired patient tumor cores and white matter-invading cell populations. Changes in gene expression in invading GBM cells were validated by quantitative reverse transcription polymerase chain reaction (QRT-PCR) and immunohistochemistry in an independent sample set. QRT-PCR confirmed the differential expression in 19 of 21 genes tested. Immunohistochemical analyses of autotaxin (ATX), ephrin B3, B-cell lymphoma-w (BCLW), and protein tyrosine kinase 2 beta showed them to be expressed in invasive glioma cells. The known GBM markers, insulin-like growth factor binding protein 2 and vimentin, were robustly expressed in the tumor core. A glioma invasion tissue microarray confirmed the expression of ATX and BCLW in invasive cells of tumors of various grades. GBM phenotypic and genotypic heterogeneity is well documented. In this study, we show an additional layer of complexity: transcriptional differences between cells of tumor core and invasive cells located in the brain parenchyma. Gene products supporting invasion may be novel targets for manipulation of brain tumor behavior with consequences on treatment outcome.
authors.affiliation: Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA.
authors.forename: Dominique B
authors.initials: DB
authors.lastname: Hoelzinger
authors.forename: Luigi
authors.initials: L
authors.lastname: Mariani
authors.forename: Joachim
authors.initials: J
authors.lastname: Weis
authors.forename: Tanja
authors.initials: T
authors.lastname: Woyke
authors.forename: Theresa J
authors.initials: TJ
authors.lastname: Berens
authors.forename: Wendy S
authors.initials: WS
authors.lastname: McDonough
authors.forename: Andrew
authors.initials: A
authors.lastname: Sloan
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Coons
authors.forename: Michael E
authors.initials: ME
authors.lastname: Berens
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D001932:Brain Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D005909:Glioblastoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007834:Lasers; D009361:Neoplasm Invasiveness / Q000235:genetics* / Q000473:pathology; D009363:Neoplasm Proteins / Q000235:genetics* / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D012333:RNA, Messenger
references.citation: Nat Immunol. 2001 Jun;2(6):493-500
references.pmid: 11376335
references.citation: Genes Dev. 2001 Jun 1;15(11):1311-33
references.pmid: 11390353
references.citation: Clin Cancer Res. 2001 Aug;7(8):2480-9
references.pmid: 11489830
references.citation: Am J Pathol. 2001 Sep;159(3):779-86
references.pmid: 11549567
references.citation: Cancer Res. 2001 Sep 15;61(18):6885-91
references.pmid: 11559565
references.citation: Brain Pathol. 2002 Jan;12(1):87-94
references.pmid: 11770904
references.citation: Brain Pathol. 2002 Jan;12(1):108-16
references.pmid: 11771519
references.citation: J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9
references.pmid: 11895036
references.citation: Biochimie. 2002 Feb-Mar;84(2-3):195-201
references.pmid: 12022950
references.citation: Clin Exp Metastasis. 2002;19(3):225-32
references.pmid: 12067203
references.citation: Neuro Oncol. 2002 Jul;4(3):179-86
references.pmid: 12084348
references.citation: Front Biosci. 2002 Aug 1;7:e339-53
references.pmid: 12133814
references.citation: Physiol Rev. 2002 Oct;82(4):893-922
references.pmid: 12270947
references.citation: Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1104-17
references.pmid: 12376404
references.citation: Cancer Res. 2002 Nov 1;62(21):6278-88
references.pmid: 12414658
references.citation: Mol Cancer Ther. 2002 Nov;1(13):1229-36
references.pmid: 12479704
references.citation: Clin Exp Metastasis. 2002;19(7):603-8
references.pmid: 12498389
references.citation: Nature. 2003 Jan 2;421(6918):83-7
references.pmid: 12511959
references.citation: Brain Pathol. 2003 Jan;13(1):52-61
references.pmid: 12580545
references.citation: J Cell Biol. 2003 Feb 17;160(4):565-75
references.pmid: 12578912
references.citation: Cancer Res. 2003 Mar 1;63(5):1093-100
references.pmid: 12615727
references.citation: Mol Cancer Res. 2003 Mar;1(5):323-32
references.pmid: 12651906
references.citation: Cancer Res. 2003 Apr 1;63(7):1602-7
references.pmid: 12670911
references.citation: Science. 2003 Apr 4;300(5616):135-9
references.pmid: 12624178
references.citation: J Clin Oncol. 2003 Apr 15;21(8):1624-36
references.pmid: 12697889
references.citation: Oncogene. 2003 Apr 17;22(15):2361-73
references.pmid: 12700671
references.citation: J Exp Clin Cancer Res. 2003 Jun;22(2):299-306
references.pmid: 12866581
references.citation: Cancer J. 2003 May-Jun;9(3):180-8
references.pmid: 12952303
references.citation: J Cell Sci. 2003 Nov 1;116(Pt 21):4409-17
references.pmid: 13130092
references.citation: Acta Neurochir Suppl. 2003;88:153-62
references.pmid: 14531573
references.citation: Int J Oncol. 2003 Dec;23(6):1697-702
references.pmid: 14612943
references.citation: J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):763-8
references.pmid: 10567494
references.citation: Biochem Cell Biol. 2000;78(5):569-75
references.pmid: 11103947
references.citation: Cancer Res. 2000 Dec 1;60(23):6617-22
references.pmid: 11118044
references.citation: Int J Oncol. 2001 Feb;18(2):287-95
references.pmid: 11172594
references.citation: Cancer Res. 2001 May 15;61(10):4190-6
references.pmid: 11358844
references.citation: J Neurosci. 2001 May 15;21(10):3360-8
references.pmid: 11331365
references.citation: Cell Motil Cytoskeleton. 2004 Feb;57(2):84-95
references.pmid: 14691948
references.citation: J Biol Chem. 2004 Feb 6;279(6):4136-43
references.pmid: 14627715
references.citation: J Neurosurg. 1983 Feb;58(2):159-69
references.pmid: 6294260
references.citation: Cancer. 1989 Jul 15;64(2):442-7
references.pmid: 2736491
references.citation: J Biol Chem. 1992 Feb 5;267(4):2524-9
references.pmid: 1733949
references.citation: J Biol Chem. 1993 May 25;268(15):10709-12
references.pmid: 8496137
references.citation: Cancer. 1995 Jun 15;75(12):2904-9
references.pmid: 7773941
references.citation: Int J Cancer. 1996 Jul 17;67(2):275-82
references.pmid: 8760599
references.citation: Mol Cell Biol. 1996 Sep;16(9):5069-80
references.pmid: 8756665
references.citation: J Neurosurg. 1997 Sep;87(3):420-30
references.pmid: 9285609
references.citation: Acta Neurochir (Wien). 1997;139(9):845-50
references.pmid: 9351989
references.citation: Anticancer Res. 1997 Nov-Dec;17(6B):4145-9
references.pmid: 9428348
references.citation: Nat Med. 1998 Jul;4(7):844-7
references.pmid: 9662379
references.citation: Cancer Res. 1999 Sep 1;59(17):4228-32
references.pmid: 10485462
references.citation: J Neuropathol Exp Neurol. 1999 Oct;58(10):1029-40
references.pmid: 10515226